ScripThe founder of India’s Strides group, Arun Kumar, who holds a substantial stake in Sterling Pharma Solutions, is believed to be considering a sale of his holding in the UK-based contract development a
In VivoThe contract drug delivery market has evolved in line with several different factors: financing, client base, and product innovation. Once a vibrant sub-set of the outsourced offerings to the biopharm
In VivoFinancings Total biopharma financing during the fourth quarter of 2017 amounted to $14.5 billion, a strong finish to a year that benefitted from renewed investor confidence in the industry and an open
In VivoDevice Transactions Financing by device companies in the third quarter of 2017 totaled $2.38 billion, double Q2's $1.2 billion. ( See Exhibit 1. ) Debt again this quarter made up most of the aggregate